Investing

Acquisitions and In-Process R&D

Abbott Acquisitions and In-Process R&D increased by 98890.0% to $19.80B in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionInvesting
First reportedQ1 2017
Last reportedQ1 2026Apr 29, 2026
Metric ID: abt_acquisitions_and_iprd

Historical Data

11 periods
 Q3 '21Q3 '22Q4 '22Q3 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$172.00M$0.00$0.00$51.00M$0.00$0.00$0.00$30.00M$55.00M$20.00M$19.80B
QoQ Change-100.0%-100.0%+83.3%-63.6%>999%
YoY Change-100.0%-100.0%
Range$0.00$19.80B
CAGR+567.5%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Abbott's acquisitions and in-process r&d?
Abbott (ABT) reported acquisitions and in-process r&d of $19.80B in Q1 2026.